Atlas Trials

Phase II Randomized Study of Muromonab-CD3, Cyclosporine, Methylprednisolone, and Prednisone in Patients With Giant Cell Myocarditis

Clinical trial NCT00004482 · COMPLETED

Trial details

NCT number
NCT00004482
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
MyocarditisGiant Cell Myocarditis
Start date
1999-12-01
Primary completion
2005-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.